RBCC has acquired a new equity interest in Nano3D Biosciences, Inc. (n3D). - not according to their financials. At best they have invested a couple hundred dollars equating to a 0.0018% equity stake.
n3D's nanoparticle technology could completely revolutionize cell research - RBCC has no agreement to profit in the unlikely event n3D's technology ever comes to fruition.
RBCC is spearheading the most innovative scientific and medical breakthroughs - RBCC is doing NOTHING to spearhead ANYTHING - name ONE?!
U.S. biotech companies raised $25 billion in 2010 - RBCC is a fish farm company - it has NO biotech assets, NO management experience, nada, zilch...
RBCC is joining the ranks of bioscience companies like... - RBCC is NOT a bioscience company, QUIT spamming the board!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.